Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

A New Severe Congenital Neutropenia Syndrome Associated with Autosomal Recessive COPZ1 Mutations

Blood blood.2023022576.

https://doi.org/10.1182/blood.2023022576

Published: 2024

Includes: Supplemental data

Journal Articles

Long-Term Immunological Consequences of CD19 CAR T Cell Therapy: Analysis of Infectious Complications and Immune Reconstitution

Andreas Riedel, Jan Frederic Weller, Laurent Phely, Stefan Hug, Christoph Faul, Claudia Lengerke, Wolfgang Andreas Bethge

Blood (2024) 144 (Supplement 1): 7248.

https://doi.org/10.1182/blood-2024-210536

Published: 2024

Journal Articles

Dual CD19/CD22-Targeting CAR-T Cells for Richter Transformation: A Case Series

Stefan Hug, Laurent Phely, Andreas Riedel, Simon Killinger, Luca Hensen, Christoph Faul, Wolfgang Andreas Bethge, Claudia Lengerke

Blood (2024) 144 (Supplement 1): 6544.

https://doi.org/10.1182/blood-2024-200768

Published: 2024

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation Post-Sars-Cov-2 Infection: A Retrospective Analysis By the German Cooperative Transplant Study Group

Blood (2024) 144 (Supplement 1): 3554.

https://doi.org/10.1182/blood-2024-204560

Published: 2024

Journal Articles

Primary Vitreoretinal Lymphoma: A Comprehensive Retrospective Analysis of 65 Cases at Two European Centers

Sina Alexandra Beer, Carola Huber, Michael Sommer, Stefan Wirths, Daniela Süsskind, Claudia Lengerke, David Adrian Merle

Blood (2024) 144 (Supplement 1): 4464.

https://doi.org/10.1182/blood-2024-203779

Published: 2024

Journal Articles

Flavopiridol Restores Granulopoiesis in an Experimental Model of Severe Congenital Neutropenia

Benjamin Dannenmann, Masoud Nasri, Larissa Doll, Betül Findik, Franka Bernhard, Sergey Kandabarau, Maksim Klimiankou, Claudia Lengerke, Cornelia Zeidler, Karl Welte, Julia Skokowa

Blood (2024) 144 (Supplement 1): 419.

https://doi.org/10.1182/blood-2024-209864

Published: 2024

Journal Articles

Autosomal Recessive COPZ1 Mutations Cause Isolated Severe Neutropenia or Complex Syndrome with Severe Neutropenia

Blood (2024) 144 (Supplement 1): 417.

https://doi.org/10.1182/blood-2024-199069

Published: 2024

Journal Articles

Modulating G-CSFR Signaling Using De Novo Designed Cytokines

Timo Ullrich, Birte Hernandez Alvarez, Christoph Pollmann, Malte Ulrich Ritter, Jérémy Haaf, Narges Aghaallaei, Jacob Piehler, Ivan Tesakov, Maya El-Riz, Kateryna Maksymenko, Valeriia Hatskovska, Sergey Kandabarau, Maksim Klimiankou, Claudia Lengerke, Karl Welte, Andrei Lupas, Julia Skokowa, Mohammad ElGamacy

Blood (2024) 144 (Supplement 1): 4967.

https://doi.org/10.1182/blood-2024-209668

Published: 2024

Journal Articles

Outcomes of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Multicenter Real-World Analysis

Blood (2024) 144 (Supplement 1): 3818.

https://doi.org/10.1182/blood-2024-211227

Published: 2024

Journal Articles

MRC2+ AML Stem Cells Reveal the Role of Proline Metabolism in Venetoclax Resistance

Taylor Scott Mills, Marlon Arnone, Simone Poeschel, Stefan Winter, Jessica Kuebler, Jan Frederic Weller, Anna Maria Stanger, Matthias Schwab, Claudia Lengerke

Blood (2024) 144 (Supplement 1): 49.

https://doi.org/10.1182/blood-2024-198643

Published: 2024

Journal Articles

Characterization of a Human Bone Marrow-Derived CRISPR/Cas9 Cell Model for Chronic Myeloid Leukemia

Pia Christin Radszuweit, Barbara Mankel, Fulya Korkmaz, Hildegard Keppeler, Claudia Lengerke, Dominik Schneidawind, Corina Schneidawind

Blood (2024) 144 (Supplement 1): 1353.

https://doi.org/10.1182/blood-2024-209947

Published: 2024

Journal Articles

Patients with High-Risk Myelodysplastic Neoplasms Do Not Benefit from Remission Induction with Azacitidine Prior to Hematopoietic Cell Transplantation: A Retrospective, Single-Center Analysis with Extended Follow-up

Jan Christian Schröder, Jan Frederic Weller, Philipp Faustmann, Lucas Mix, Christoph Faul, Claudia Lengerke, Wolfgang Andreas Bethge

Blood (2023) 142 (Supplement 1): 2231.

https://doi.org/10.1182/blood-2023-174430

Published: 2023

Journal Articles

A Universal CRISPR/Cas9n-Mediated Genome Editing Approach for ELANE -Related Severe Congenital Neutropenia

Masoud Nasri, Malte Ulrich Ritter, Perihan Mir, Benjamin Dannenmann, Masako Monika Kaufmann, Yun Xu, Natalia Borbaran-Bravo, Maksim Klimiankou, Claudia Lengerke, Cornelia Zeidler, Toni Cathomen, Karl Welte, Julia Skokowa

Blood (2023) 142 (Supplement 1): 932.

https://doi.org/10.1182/blood-2023-181678

Published: 2023

Journal Articles

Allogeneic Hematopoietic Cell Transplant Recipients Carrying DNMT3A and ASXL1 Mutations More Frequently Develop Severe Graft Versus Host Disease and Arterial Hypertension

Alisha Weiss-Haug, Reka A Haraszti, Britta Merz, Kristina Reuss, Christoph Faul, Wolfgang Andreas Bethge, Frederike Schwartz, Wichard Vogel, Claudia Lengerke

Blood (2023) 142 (Supplement 1): 3564.

https://doi.org/10.1182/blood-2023-188752

Published: 2023

Journal Articles

Prospective Evaluation of Patient-Reported Outcome up to 10 Years after Allogeneic Stem Cell Transplantation Using FACT-G/BMT and EORTC-QLQ30 Questionnaires

Sina Alexandra Beer, Johanna Blaettel, Kristina Reuss, Jan Christian Schröder, Wichard Vogel, Christoph Faul, Wolfgang Andreas Bethge, Claudia Lengerke

Blood (2023) 142 (Supplement 1): 2208.

https://doi.org/10.1182/blood-2023-188833

Published: 2023

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Metachromatic Leukodystrophy (MLD): A Case Series

Andreas Riedel, Christoph Faul, Kristina Reuss, Peter Lang, Claudia Lengerke, Nadine Weissert, Holger Hengel, Ludger Schoels, Wolfgang Andreas Bethge

Blood (2023) 142 (Supplement 1): 7115.

https://doi.org/10.1182/blood-2023-187317

Published: 2023

Journal Articles

Rational Combinatorial Targeting By Adapter CAR T Cells (AdCAR-T) Prevents Antigen Escape in Acute Myeloid Leukemia (AML)

Blood (2023) 142 (Supplement 1): 6834.

https://doi.org/10.1182/blood-2023-185093

Published: 2023

Journal Articles

BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis

Blood (2023) 142 (13): 1143–1155.

https://doi.org/10.1182/blood.2022019274

Published: 2023

Includes: Supplemental data

Journal Articles

The Rorɣ/SREBP2 Pathway Is a Master Regulator of Cholesterol Metabolism and Serves As Potential Therapeutic Target in T(4;11) Leukemia

Estelle Erkner, Thomas Hentrich, Rahel Fitzel, Hildegard Keppeler, Fulya Korkmaz, Johan Jeong, Julia Schulze-Hentrich, Claudia Lengerke, Dominik Schneidawind, Corina Schneidawind

Blood (2022) 140 (Supplement 1): 2999–3000.

https://doi.org/10.1182/blood-2022-169267

Published: 2022

Journal Articles

The Role of Mannose Receptor C-Type 2 (MRC2) in Leukemic Stem Cell Maintenance in AML

Marlon Arnone, Elsa Görsch, Simone Pöschel, Anna Stanger, Saskia Rudat, Claudia Lengerke

Blood (2022) 140 (Supplement 1): 8706.

https://doi.org/10.1182/blood-2022-156799

Published: 2022

NARROW

A New Severe Congenital Neutropenia Syndrome Associated with Autosomal Recessive COPZ1 Mutations

Long-Term Immunological Consequences of CD19 CAR T Cell Therapy: Analysis of Infectious Complications and Immune Reconstitution

Dual CD19/CD22-Targeting CAR-T Cells for Richter Transformation: A Case Series

Impact of Allogeneic Hematopoietic Cell Transplantation Post-Sars-Cov-2 Infection: A Retrospective Analysis By the German Cooperative Transplant Study Group

Primary Vitreoretinal Lymphoma: A Comprehensive Retrospective Analysis of 65 Cases at Two European Centers

Flavopiridol Restores Granulopoiesis in an Experimental Model of Severe Congenital Neutropenia

Autosomal Recessive COPZ1 Mutations Cause Isolated Severe Neutropenia or Complex Syndrome with Severe Neutropenia

Modulating G-CSFR Signaling Using De Novo Designed Cytokines

Outcomes of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Multicenter Real-World Analysis

MRC2+ AML Stem Cells Reveal the Role of Proline Metabolism in Venetoclax Resistance

Characterization of a Human Bone Marrow-Derived CRISPR/Cas9 Cell Model for Chronic Myeloid Leukemia

Patients with High-Risk Myelodysplastic Neoplasms Do Not Benefit from Remission Induction with Azacitidine Prior to Hematopoietic Cell Transplantation: A Retrospective, Single-Center Analysis with Extended Follow-up

A Universal CRISPR/Cas9n-Mediated Genome Editing Approach for ELANE -Related Severe Congenital Neutropenia

Allogeneic Hematopoietic Cell Transplant Recipients Carrying DNMT3A and ASXL1 Mutations More Frequently Develop Severe Graft Versus Host Disease and Arterial Hypertension

Prospective Evaluation of Patient-Reported Outcome up to 10 Years after Allogeneic Stem Cell Transplantation Using FACT-G/BMT and EORTC-QLQ30 Questionnaires

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Metachromatic Leukodystrophy (MLD): A Case Series

Rational Combinatorial Targeting By Adapter CAR T Cells (AdCAR-T) Prevents Antigen Escape in Acute Myeloid Leukemia (AML)

BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis

The Rorɣ/SREBP2 Pathway Is a Master Regulator of Cholesterol Metabolism and Serves As Potential Therapeutic Target in T(4;11) Leukemia

The Role of Mannose Receptor C-Type 2 (MRC2) in Leukemic Stem Cell Maintenance in AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only